Mirna Therapeutics

Last updated: May 01, 2024

Matthew Winkler, Founder
Matthew Winkler, Founder
Country: USA | Funding: $109.9M (+)

Website: http://www.mirnatherapeutics.com/

Mirna is a clinical-stage biopharmaceutical company developing a broad pipeline of leading microRNA-based oncology therapeutics, the first to demonstrate clinical proof of concept for microRNA replacement therapy.